Deferasirox is an active pharmaceutical ingredient used in the manufacturing of medications for iron chelation therapy. It is a tridentate iron(III)-selective chelator with a triazole backbone, characterized by its aromatic rings and carboxylic acid group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Deferasirox?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Deferasirox Methyl Ester
pharmaceutical intermediate
Choline salicylate
pharmaceutical raw material
Amiloride hydrochloride
pharmaceutical raw material
Sivelestat sodium tetrahydrate
pharmaceutical raw material
Taltirelin hydrate
pharmaceutical raw material
4-[(3E,5E)-3,5-Bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl](²H₄)benzoic acid
research compound
The international HS code for Deferasirox (CAS 201530-41-8) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid
BOFQWVMAQOTZIW-UHFFFAOYSA-N
C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O
Sourcing Deferasirox?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.